Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation

BACKGROUND: Though warfarin has historically been the primary oral anticoagulant for stroke prevention in newly diagnosed atrial fibrillation (AF), several new direct oral anticoagulants may be preferred when anticoagulation control with warfarin is expected to be poor. This study developed a predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Brent A., Evans, Michael A., Honushefsky, Ashley M., Berger, Peter B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721868/
https://www.ncbi.nlm.nih.gov/pubmed/29025746
http://dx.doi.org/10.1161/JAHA.117.006669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721868/
https://www.ncbi.nlm.nih.gov/pubmed/29025746
http://dx.doi.org/10.1161/JAHA.117.006669

Ejemplares similares